|
FTSJD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.419000E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.317000E-03 |
| Normal-vs-Stage2 |
2.655600E-01 |
| Normal-vs-Stage3 |
3.416500E-04 |
| Normal-vs-Stage4 |
1.970240E-04 |
| Stage1-vs-Stage2 |
4.946000E-01 |
| Stage1-vs-Stage3 |
1.080810E-01 |
| Stage1-vs-Stage4 |
5.007600E-02 |
| Stage2-vs-Stage3 |
1.002200E-01 |
| Stage2-vs-Stage4 |
4.989800E-02 |
| Stage3-vs-Stage4 |
4.928400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.363600E-04 |
| Normal-vs-AfricanAmerican |
2.069800E-02 |
| Normal-vs-Asian |
1.882040E-01 |
| Caucasian-vs-AfricanAmerican |
8.971800E-01 |
| Caucasian-vs-Asian |
1.887360E-01 |
| AfricanAmerican-vs-Asian |
3.105400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.539380E-03 |
| Normal-vs-Female |
2.822900E-03 |
| Male-vs-Female |
3.296400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.445680E-02 |
| Normal-vs-Age(41-60Yrs) |
1.444330E-03 |
| Normal-vs-Age(61-80Yrs) |
3.476100E-03 |
| Normal-vs-Age(81-100Yrs) |
4.409600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.624600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.040000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.272800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.716800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.469200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.352400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.286000E-02 |
| Classical-VS-Follicular |
3.656800E-01 |
| Classical-VS-Other |
2.948000E-01 |
| Classical-VS-Normal |
1.964360E-02 |
| Tall-VS-Follicular |
9.275700E-02 |
| Tall-VS-Other |
8.939600E-01 |
| Tall-VS-Normal |
1.215090E-04 |
| Follicular-VS-Other |
5.128600E-01 |
| Follicular-VS-Normal |
1.271770E-02 |
| Other-VS-Normal |
3.177700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.735800E-03 |
| Normal-vs-N1 |
8.631400E-04 |
| N0-vs-N1 |
2.362200E-01 |
|
|
